Ki67 assessment protocol as an integral biomarker for avoiding radiotherapy in the LUMINA breast cancer trial.
Histopathology(2023)
Abstract
ClinicalTrials.gov number, NCT01791829.
MoreTranslated text
Key words
Ki67,LUMINA,biomarker,breast cancer,clinical trial,immunohistochemistry,radiotherapy
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined